Quantbot Technologies LP Seagen Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $217,956 - $258,438	-1,857 Reduced 72.71%	697 $89,000
Q3 2022 Nov 07, 2022	BUY	$135.27 - $180.11 $309,362 - $411,911	2,287 Added 856.55%	2,554 $349,000
Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $29,052 - $47,881	267 New	267 $47,000
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $304,527 - $401,886	-2,546 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $362,983 - $485,929	2,546 New	2,546 $393,000
Q3 2021 Nov 09, 2021	SELL	$142.45 - $169.82 $760,540 - $906,668	-5,339 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $861,135 - $1.03 Million	-6,375 Reduced 54.42%	5,339 $842,000
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $1.38 Million - $1.91 Million	-10,028 Reduced 46.12%	11,714 $1.63 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $3.58 Million - $4.61 Million	21,742 New	21,742 $3.81 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.